Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway*. (7th February 2016)
- Record Type:
- Journal Article
- Title:
- Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway*. (7th February 2016)
- Main Title:
- Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway*
- Authors:
- Wang, Siyuan
Chen, Cheng
Su, Ke
Zha, Dongqing
Liang, Wei
Hillebrands, JL
Goor, Harry van
Ding, Guohua - Abstract:
- Abstract: Aims In the present study, we have evaluated the effect of angiotensin II (Ang II) on actin cytoskeleton reorganization and myosin light-chain (MLC) phosphorylation in podocytes to demonstrate whether the Rho/Rho-associated coiled kinase (ROCK) pathway is involved podocyte injury.Methods Eighteen male Sprague–Dawley rats were divided into three groups and treated with Ang II, saline or telmisartan. Morphological changes were studied at 28 days after treatment. Immunohistochemistry and Western blotting were used to determine the renal expression of p-MLC and ROCK2. Cultured podocytes were treated with Ang II (10 −7 M) with or without Rho-kinase inhibitor (Y27632, 10 −6 M) for variable time periods. F-actin was visualized with fluorescein isothiocyanate (FITC)-conjugated phalloidin or tetraethyl rhodamine isothiocyanate (TRITC)-conjugated phalloidin. p-MLC expression was evaluated by immunofluorescence and Western blot. The activation of Rho/ROCK was evaluated by Western blot.Results The expression of p-MLC in glomeruli increased significantly in rats treated with Ang II when compared to the control rats as shown by Western blot ( p < 0.05). In cultured podocytes, Rho A and ROCK2 increased after incubation with Ang II. Ang II increased the expression of ROCK2, which was accompanied with altered morphology, redistribution of actin and increased phosphorylation of MLC. The distribution of actin changed to a large extent, although overall quantitative differencesAbstract: Aims In the present study, we have evaluated the effect of angiotensin II (Ang II) on actin cytoskeleton reorganization and myosin light-chain (MLC) phosphorylation in podocytes to demonstrate whether the Rho/Rho-associated coiled kinase (ROCK) pathway is involved podocyte injury.Methods Eighteen male Sprague–Dawley rats were divided into three groups and treated with Ang II, saline or telmisartan. Morphological changes were studied at 28 days after treatment. Immunohistochemistry and Western blotting were used to determine the renal expression of p-MLC and ROCK2. Cultured podocytes were treated with Ang II (10 −7 M) with or without Rho-kinase inhibitor (Y27632, 10 −6 M) for variable time periods. F-actin was visualized with fluorescein isothiocyanate (FITC)-conjugated phalloidin or tetraethyl rhodamine isothiocyanate (TRITC)-conjugated phalloidin. p-MLC expression was evaluated by immunofluorescence and Western blot. The activation of Rho/ROCK was evaluated by Western blot.Results The expression of p-MLC in glomeruli increased significantly in rats treated with Ang II when compared to the control rats as shown by Western blot ( p < 0.05). In cultured podocytes, Rho A and ROCK2 increased after incubation with Ang II. Ang II increased the expression of ROCK2, which was accompanied with altered morphology, redistribution of actin and increased phosphorylation of MLC. The distribution of actin changed to a large extent, although overall quantitative differences were not observed. Addition of Y-27632 to podocytes treated with Ang II could ameliorate F-actin cytoskeleton remodeling and the increment in p-MLC expression.Conclusion Ang II-induced podocyte cytoskeleton protein expression changing through the RhoA/ROCK2 p-MLC/F-actin pathway. … (more)
- Is Part Of:
- Renal failure. Volume 38:Number 2(2016)
- Journal:
- Renal failure
- Issue:
- Volume 38:Number 2(2016)
- Issue Display:
- Volume 38, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 38
- Issue:
- 2
- Issue Sort Value:
- 2016-0038-0002-0000
- Page Start:
- 268
- Page End:
- 275
- Publication Date:
- 2016-02-07
- Subjects:
- Podocyte -- myosin light chain -- Rho/ROCK pathway -- angiotensin II -- telmisartan -- ROCK inhibitor
Chronic renal failure -- Periodicals
Acute renal failure -- Periodicals
Uremia -- Periodicals
616.614005 - Journal URLs:
- http://informahealthcare.com/journal/rnf ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/titles/0886022x.asp ↗ - DOI:
- 10.3109/0886022X.2015.1117896 ↗
- Languages:
- English
- ISSNs:
- 0886-022X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7356.869800
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5954.xml